{"id":192,"date":"2026-03-17T05:13:28","date_gmt":"2026-03-17T05:13:28","guid":{"rendered":"https:\/\/senopeptide.com\/?post_type=product&p=192"},"modified":"2026-05-26T03:04:15","modified_gmt":"2026-05-26T03:04:15","slug":"seno-retatrutide-lyophilized-powder-bulk-wholesale-price","status":"publish","type":"product","link":"https:\/\/senopeptide.com\/ru\/seno-retatrutide-lyophilized-powder-bulk-wholesale-price\/","title":{"rendered":"SENO \u0440\u0435\u0442\u0430\u0442\u0440\u0443\u0442\u0438\u0434 \u043b\u0438\u043e\u0444\u0438\u043b\u0438\u0437\u0438\u0440\u043e\u0432\u0430\u043d\u043d\u044b\u0439 \u043f\u043e\u0440\u043e\u0448\u043e\u043a \u043e\u043f\u0442\u043e\u0432\u0430\u044f \u0446\u0435\u043d\u0430"},"content":{"rendered":"
\n
\n
\n
\n
\n
\n
\n
<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n<\/div>\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
Multi-Receptor Agonist Peptide<\/a> for Metabolic & Endocrine Research<\/span><\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n<\/div>\n
\n
\n
\n
\n
\n
\n
\n
\n

Retatrutide is a next-generation synthetic research peptide investigated for its triple receptor agonist activity involving GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors. Its multi-pathway mechanism has made it an important compound in advanced metabolic, obesity, endocrine, and receptor-signaling research models.<\/p>\n

SENO supplies high-purity Retatrutide lyophilized powder in multiple research specifications ranging from 5mg to 100mg per vial set. Each batch is manufactured using automated solid-phase peptide synthesis (SPPS), purified by preparative HPLC, and verified using analytical mass spectrometry.<\/p>\n

Available specifications:<\/p>\n

    \n
  • RT5 \u2014 5mg \u00d7 10 vials<\/li>\n
  • RT10 \u2014 10mg \u00d7 10 vials<\/li>\n
  • RT15 \u2014 15mg \u00d7 10 vials<\/li>\n
  • RT20 \u2014 20mg \u00d7 10 vials<\/li>\n
  • RT30 \u2014 30mg \u00d7 10 vials<\/li>\n
  • RT40 \u2014 40mg \u00d7 10 vials<\/li>\n
  • RT50 \u2014 50mg \u00d7 10 vials<\/li>\n
  • RT60 \u2014 60mg \u00d7 10 vials<\/li>\n
  • RT100 \u2014 100mg \u00d7 10 vials<\/li>\n<\/ul>\n

    This peptide is supplied exclusively for laboratory research applications.<\/p>\n

    \n

    What Is Retatrutide?<\/h2>\n

    Retatrutide is a synthetic multi-receptor agonist peptide designed to simultaneously target:<\/p>\n

      \n
    • GLP-1 receptors<\/li>\n
    • GIP receptors<\/li>\n
    • glucagon receptors<\/li>\n<\/ul>\n

      Its molecular structure was developed to investigate how combined receptor activation influences:<\/p>\n

        \n
      • metabolic regulation<\/li>\n
      • energy expenditure<\/li>\n
      • glucose metabolism<\/li>\n
      • hormonal signaling<\/li>\n
      • receptor crosstalk mechanisms<\/li>\n<\/ul>\n

        Unlike single-pathway peptide compounds, Retatrutide is studied for its ability to activate multiple metabolic signaling systems simultaneously, making it highly relevant in obesity, endocrine, and receptor pharmacology research.<\/p>\n

        The peptide is typically supplied as a white lyophilized powder to preserve structural stability during storage and transport.<\/p>\n

        \n

        Research Applications<\/h2>\n

        Retatrutide is widely used in advanced laboratory investigations involving:<\/p>\n

          \n
        • GLP-1 receptor pathway studies<\/li>\n
        • GIP receptor signaling research<\/li>\n
        • glucagon receptor modulation analysis<\/li>\n
        • metabolic pathway investigations<\/li>\n
        • obesity and energy balance models<\/li>\n
        • endocrine system research<\/li>\n
        • receptor-binding affinity studies<\/li>\n
        • peptide pharmacodynamics analysis<\/li>\n
        • multi-hormonal signaling experiments<\/li>\n
        • preclinical metabolic research<\/li>\n<\/ul>\n

          Its triple agonist profile makes Retatrutide particularly valuable in studies exploring synergistic receptor interactions and integrated metabolic regulation.<\/p>\n

          \n

          Molecular Formula<\/h2>\n

          C221H342N46O68C_{221}H_{342}N_{46}O_{68}<\/span>C<\/span>221<\/span><\/span><\/span>\u200b<\/span><\/span><\/span><\/span><\/span>H<\/span>342<\/span><\/span><\/span>\u200b<\/span><\/span><\/span><\/span><\/span>N<\/span>46<\/span><\/span><\/span>\u200b<\/span><\/span><\/span><\/span><\/span>O<\/span>68<\/span><\/span><\/span>\u200b<\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n

          \n

          Molecular Weight<\/h2>\n

          4837.4\u00a0g\/mol4837.4\\ g\/mol<\/span>4837.4<\/span>\u00a0<\/span>g<\/span>\/<\/span>m<\/span>o<\/span>l<\/span><\/span><\/span><\/span><\/span><\/p>\n

          \n

          CAS Number<\/h2>\n
          \n
          \n\n\n\n\n\n\n\n\n\n
          Parameter<\/th>\nDetails<\/th>\n<\/tr>\n<\/thead>\n
          Product Name<\/td>\nRetatrutide<\/td>\n<\/tr>\n
          CAS Number<\/td>\n2381089-83-2<\/td>\n<\/tr>\n
          Molecular Type<\/td>\nSynthetic peptide<\/td>\n<\/tr>\n
          Form<\/td>\nLyophilized powder<\/td>\n<\/tr>\n
          Purity<\/td>\n\u226598% (HPLC verified)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n
          \n

          Product Specifications<\/h2>\n
          \n
          \n\n\n\n\n\n\n\n\n\n\n\n\n\n
          Product Code<\/th>\nSpecification<\/th>\nForm<\/th>\n<\/tr>\n<\/thead>\n
          RT5<\/td>\n5mg \u00d7 10 vials<\/td>\nLyophilized powder<\/td>\n<\/tr>\n
          RT10<\/td>\n10mg \u00d7 10 vials<\/td>\nLyophilized powder<\/td>\n<\/tr>\n
          RT15<\/td>\n15mg \u00d7 10 vials<\/td>\nLyophilized powder<\/td>\n<\/tr>\n
          RT20<\/td>\n20mg \u00d7 10 vials<\/td>\nLyophilized powder<\/td>\n<\/tr>\n
          RT30<\/td>\n30mg \u00d7 10 vials<\/td>\nLyophilized powder<\/td>\n<\/tr>\n
          RT40<\/td>\n40mg \u00d7 10 vials<\/td>\nLyophilized powder<\/td>\n<\/tr>\n
          RT50<\/td>\n50mg \u00d7 10 vials<\/td>\nLyophilized powder<\/td>\n<\/tr>\n
          RT60<\/td>\n60mg \u00d7 10 vials<\/td>\nLyophilized powder<\/td>\n<\/tr>\n
          RT100<\/td>\n100mg \u00d7 10 vials<\/td>\nLyophilized powder<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n
          \n

          Mechanism of Action<\/h2>\n

          Retatrutide is investigated as a triple receptor agonist capable of interacting with:<\/p>\n

            \n
          • GLP-1 receptors<\/li>\n
          • GIP receptors<\/li>\n
          • glucagon receptors<\/li>\n<\/ul>\n

            This multi-target mechanism is studied for its effects on metabolic signaling networks and energy homeostasis.<\/p>\n

            Primary research interests include:<\/p>\n

            GLP-1 Receptor Activity<\/h3>\n

            Associated with investigations into:<\/p>\n

              \n
            • glucose regulation<\/li>\n
            • insulin signaling<\/li>\n
            • appetite-related pathways<\/li>\n<\/ul>\n

              GIP Receptor Activity<\/h3>\n

              Studied in relation to:<\/p>\n

                \n
              • incretin biology<\/li>\n
              • metabolic modulation<\/li>\n
              • hormonal signaling coordination<\/li>\n<\/ul>\n

                Glucagon Receptor Activity<\/h3>\n

                Researched for potential influence on:<\/p>\n

                  \n
                • energy expenditure<\/li>\n
                • lipid metabolism<\/li>\n
                • hepatic metabolic pathways<\/li>\n<\/ul>\n

                  The simultaneous activation of these receptor systems makes Retatrutide distinct from traditional single-pathway metabolic peptides.<\/p>\n

                  \n

                  Solubility<\/h2>\n

                  Retatrutide is generally soluble in:<\/p>\n

                    \n
                  • sterile water<\/li>\n
                  • bacteriostatic water<\/li>\n
                  • phosphate-buffered saline (PBS)<\/li>\n
                  • selected research buffers<\/li>\n<\/ul>\n

                    Solubility characteristics may vary depending on:<\/p>\n

                      \n
                    • preparation concentration<\/li>\n
                    • pH conditions<\/li>\n
                    • temperature<\/li>\n
                    • experimental protocol<\/li>\n<\/ul>\n

                      Researchers commonly prepare aliquots to reduce repeated freeze-thaw exposure after reconstitution.<\/p>\n

                      \n

                      Storage Recommendations<\/h2>\n

                      For optimal peptide stability:<\/p>\n

                        \n
                      • Store lyophilized powder at -20\u00b0C<\/li>\n
                      • Protect from direct light and moisture<\/li>\n
                      • Avoid repeated temperature fluctuations<\/li>\n
                      • Use sterile handling procedures during preparation<\/li>\n<\/ul>\n

                        After reconstitution:<\/p>\n

                          \n
                        • Store at 2\u20138\u00b0C for short-term use<\/li>\n
                        • Minimize freeze-thaw cycles<\/li>\n
                        • Use freshly prepared solutions whenever possible<\/li>\n<\/ul>\n
                          \n

                          Stability Information<\/h2>\n

                          Retatrutide is supplied in lyophilized form to improve long-term structural stability and reduce degradation risk during transport and storage.<\/p>\n

                          Peptide stability may be affected by:<\/p>\n

                            \n
                          • oxidation<\/li>\n
                          • hydrolysis<\/li>\n
                          • temperature exposure<\/li>\n
                          • pH conditions<\/li>\n
                          • repeated freeze-thaw cycles<\/li>\n
                          • microbial contamination<\/li>\n<\/ul>\n

                            Lyophilization helps maintain peptide integrity by reducing moisture exposure during storage.<\/p>\n

                            \n

                            Research Studies & Scientific Interest<\/h2>\n

                            Retatrutide has become a major subject of interest in metabolic and endocrine research due to its simultaneous receptor-targeting design.<\/p>\n

                            Current areas of laboratory investigation include:<\/p>\n